These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2039862)

  • 1. Determinants of response and prediction of response to chemotherapy in acute myelogenous leukemia.
    Preisler HD
    Baillieres Clin Haematol; 1991 Jan; 4(1):69-96. PubMed ID: 2039862
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of intensive postinduction chemotherapy in the management of patients with acute myelogenous leukemia.
    Mayer RJ; Weinstein HJ; Coral FS; Rosenthal DS; Frei E
    Cancer Treat Rep; 1982 Jul; 66(7):1455-62. PubMed ID: 7046925
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prediction of the response to chemotherapy in acute leukemia through in-vitro incorporation of tritiated thymidine].
    Zittoun R; Bouchard M; Facquet-Danis J; Percie-Du-Sert M; Bousser J
    Ann Med Interne (Paris); 1974 Nov; 125(11):811-6. PubMed ID: 4618066
    [No Abstract]   [Full Text] [Related]  

  • 4. The therapy of acute myelogenous leukemia, a major challenge of onco-hematology.
    Boiron M
    Pathol Biol (Paris); 1986 Mar; 34(3):153-6. PubMed ID: 3517783
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of acute myelogenous leukaemia.
    Marie JP; Zittoun R
    Baillieres Clin Haematol; 1991 Jan; 4(1):97-113. PubMed ID: 2039863
    [No Abstract]   [Full Text] [Related]  

  • 6. Fludarabine for treatment of adult acute myelogenous leukemia.
    Gandhi V
    Leuk Lymphoma; 1993; 11 Suppl 2():7-13. PubMed ID: 8124234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophilic eccrine hidradenitis unassociated with chemotherapy in a patient with acute myelogenous leukemia.
    Roustan G; Salas C; Cabrera R; Simón A
    Int J Dermatol; 2001 Feb; 40(2):144-7. PubMed ID: 11328400
    [No Abstract]   [Full Text] [Related]  

  • 8. In-vitro prediction of clinical response to chemotherapy in childhood acute leukaemia. I. Combination of daunorubicin, vincristine and prednisolone.
    Laurie HC; Willoughby ML
    Br J Haematol; 1969 Sep; 17(3):251-6. PubMed ID: 5257762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long term remission in acute myelogenous leukemia in adults].
    Ly B; Gjemdal T; Stavem P
    Tidsskr Nor Laegeforen; 1978 Jan; 98(1):17-8. PubMed ID: 272750
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of drugs in cutaneous eruptions after chemotherapy for acute myelogenous leukemia.
    Mansouri S; Dubertret L; Bastuji-Garin S; Dombret H; Roujeau JC; Aractingi S
    Arch Dermatol; 1998 Jul; 134(7):881-2. PubMed ID: 9681363
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nursing care of the patient with acute myelogenous leukemia under chemotherapy].
    Kaneko Y; Takahashi S; Mukoda Y
    Kango Gijutsu; 1984 Feb; 30(3):357-62. PubMed ID: 6583433
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete cytogenetic and molecular response to treatment with imatinib mesylate for philadelphia chromosome positive acute myeloid leukemia with multilineage dysplasia.
    Ueda K; Horiike S; Zen K; Misawa S; Taniwaki M
    Leuk Lymphoma; 2006 Sep; 47(9):1967-9. PubMed ID: 17065015
    [No Abstract]   [Full Text] [Related]  

  • 13. Strategies for acute myelogenous leukemia.
    Gale RP; Butturini A
    Bone Marrow Transplant; 1991; 7 Suppl 2():58. PubMed ID: 1878721
    [No Abstract]   [Full Text] [Related]  

  • 14. [The development of new treatments of acute myelogenous leukemia].
    Kobayashi T; Nishii K
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():607-10. PubMed ID: 17474468
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute myelogenous leukemia in children].
    Lie SO
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2232-4. PubMed ID: 4531120
    [No Abstract]   [Full Text] [Related]  

  • 16. Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men.
    Russell JA; Powles RL; Oliver RT
    Br Med J; 1976 Jun; 1(6024):1508. PubMed ID: 1064461
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute myelogenous leukemia].
    Gjemdal T
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2229-32. PubMed ID: 4531119
    [No Abstract]   [Full Text] [Related]  

  • 18. The comparative value of several tests in predicting the response to chemotherapy in patients with malignant hemophathies.
    Cheţa D; Micu D; Cheţa N
    Med Interne; 1979; 17(4):353-7. PubMed ID: 390678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].
    Takeshita A
    Rinsho Ketsueki; 2003 Dec; 44(12):1133-43. PubMed ID: 14978929
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cytokinetics, chemotherapy and clinical course of acute leukemias].
    Gavosto F; Masera P; Pagliardi GL
    Minerva Med; 1975 Jul; 66(51):2534-7. PubMed ID: 1057049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.